HemoGenix is an innovative Leader in stem cell toxicity related to hematotoxicity and immunotoxicity using its HALO-Tox HT and ImmunoGlo™-Tox HT Platforms that allows potential toxicity of virtually any test compound to be compared with respect to cell population and species.
Hematotoxicity Testing
Highly predictive hematotoxicity testing for downstream effects by analyzing stem and progenitors cells from different species with multiplexing capabilities.
Analysis of T- and B-cell progenitors and immune cells to potential toxic agents as well as lymphocyte proliferation and mixed lymphocyte culture assays.